Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros

The Board of Directors of Sartorius Stedim Biotech S.A. resolved at its meeting, on February 4, 2026, to propose a dividend of 0.69 euros per share for fiscal 2025 to the combined Annual Shareholders’ Meeting on March 24, 2026 – the same amount as in 2024. The total distributed profit would be 67.1 million euros. The dividend will be paid to shareholders as from April 2, 2026.

In addition, the Board of Directors decided to submit to the Annual Shareholders’ Meeting the 2025 results of Sartorius Stedim Biotech which had already been published on a preliminary basis on February 3, 2026.

This media release contains forward-looking statements about the future development of the Sartorius Stedim Biotech Group. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Sartorius Stedim Biotech assumes no liability for updating such statements in light of new information or future events. Sartorius Stedim Biotech shall not assume any liability for the correctness of this release. The original French press release is the legally binding version.